Trump Media's stock dropped 13.5% after the company reported a net loss of $327.6 million on just $770,500 in revenue in the first quarter of 2024. The loss was mainly due to non-cash expenses, including the conversion of promissory notes and the associated elimination of prior liabilities.
Gilead Sciences' lenacapavir demonstrated 100% efficacy for HIV prevention in cisgender women in its Phase 3 trial. The results showed superiority to Gilead's already-approved oral medicines for HIV prevention, Truvada and Descovy4. The trial involved over 2,000 women who received the lenacapavir shot, with zero cases of HIV infection reported.
Super Micro Computer will help Elon Musk's AI firm, xAI, build a supercomputer. The company's shares jumped 5% following the announcement. Super Micro Computer is known for its close ties with chip manufacturers like Nvidia and its innovative liquid-cooling technology1.